Keratitis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Keratitis
NCT05891106: AONDA Therapeutic Indication Study I

Completed
N/A
55
US
Lotrafilcon A contact lenses, AONDA, AIR OPTIX® NIGHT & DAY® AQUA
Alcon Research
Bullous Keratopathy, Corneal Erosion, Entropion, Corneal Edema, Corneal Dystrophy, Corneal Ulcer, Foreign Body in Cornea, Bell Palsy, Keratoconjunctivitis, Filamentary Keratitis, Sicca Syndrome; Keratoconjunctivitis (Etiology)
07/23
07/23
PROSIKA, NCT04701086: 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Recruiting
N/A
80
Europe
Cationorm Pro, Ocutears Pro+, Vismed
Santen SAS
Dry Eye Syndromes
12/24
12/24
NCT05758753: QST for Corneal Nerve Function

Enrolling by invitation
N/A
108
US
Quantitative Sensory Test
Tufts Medical Center, Dompé Farmaceutici S.p.A
Corneal Disease, Neuropathy, Dry Eye Disease, Neurotrophic Keratitis
10/24
06/25
ALHENA, NCT04685109: 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Recruiting
N/A
80
Europe
Alocross 0.2% Unit Dose, Vismed, HA 0.18% hypotonic solution
Santen SAS
Dry Eye Syndromes
12/24
12/24
DEFENDO, NCT05552261: Long Term Follow-up Study in Stage 1 NK Patients

Recruiting
N/A
37
US
Cenegemin in the DEFENDO Study, OXERVATE™
Dompé Farmaceutici S.p.A
Neurotrophic Keratitis
09/24
09/24

Download Options